Rehmann Capital Advisory Group’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-766
| Closed | -$218K | – | 513 |
|
|
2022
Q1 | $218K | Sell |
766
-22
| -3% | -$6.25K | 0.02% | 485 |
|
|
2021
Q4 | $297K | Buy |
788
+27
| +4% | +$10.2K | 0.03% | 438 |
|
|
2021
Q3 | $314K | Buy |
761
+1
| +0.1% | +$413 | 0.03% | 425 |
|
|
2021
Q2 | $283K | Buy |
760
+10
| +1% | +$3.72K | 0.03% | 444 |
|
|
2021
Q1 | $217K | Sell |
750
-139
| -16% | -$40.3K | 0.02% | 480 |
|
|
2020
Q4 | $222K | Buy |
889
+3
| +0.3% | +$750 | 0.03% | 448 |
|
|
2020
Q3 | $201K | Buy |
+886
| New | +$201K | 0.03% | 410 |
|
|
2019
Q3 | $81.5K | Buy |
616
+221
| +56% | +$29.3K | 0.01% | 502 |
|
|
2019
Q2 | $56.1K | Sell |
395
-1
| -0.3% | -$142 | 0.01% | 791 |
|
|
2019
Q1 | $57.5K | Sell |
396
-36
| -8% | -$5.23K | 0.01% | 769 |
|
|
2018
Q4 | $48.9K | Buy |
432
+34
| +9% | +$3.85K | 0.01% | 594 |
|
|
2018
Q3 | $53.5K | Sell |
398
-4
| -1% | -$538 | 0.01% | 767 |
|
|
2018
Q2 | $45.1K | Buy |
402
+300
| +294% | +$33.7K | 0.01% | 819 |
|
|
2018
Q1 | $11K | Buy |
+102
| New | +$11K | ﹤0.01% | 1273 |
|